GSK PLC (GSK)

Industry Drug Manufacturers - General

This stock can be held in an Investment ISA, SIPP and Investment Account

Sell

1,822.50p

Buy

1,823.00p

arrow-up3.50p (+0.19%)

Prices updated at 12 Dec 2025, 17:15 GMT

Prices minimum 15 mins delay

Prices in GBX

GlaxoSmithKline PLC creates, discovers, develops, manufactures and markets pharmaceutical products including respiratory and antiviral, vaccines, over-the-counter (OTC) medicines and health-related consumer products.

FTSE All-Share

-0.48%

LSE

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Income statement

Year chevron-l-regular chevron-r-regular	2023	2024
	30,328m	31,376m
	21,763m	22,328m
	7,345m	5,542m
	24.22	17.66
	4,928m	2,575m
	9,083m	6,668m
Sales, General and administrative	9,385m	11,015m
Interest expenses	725m	640m
Provision for income taxes	756m	526m
Operating expenses	14,418m	16,786m
Income before taxes	6,064m	3,477m
Net income available to common shareholders	4,928m	2,575m
	1.216	0.632
Net interest income	-735m	-603m
Advertising and promotion	-	-
Net investment income, net	-	-
Realised capital gains (losses), net	-	-
Total benefits, claims and expenses	-	-
Earnings per share (diluted)	1.199	0.622
Free cash flow per share	0.7713	1.1593
Book value/share	3.2377	3.4326
Debt equity ratio	1.139207	1.070661

Balance sheet

Year chevron-l-regular chevron-r-regular	2023	2024
Current assets	18,644m	16,997m
Current liabilities	21,068m	21,697m
Total capital	27,501m	27,374m
Total debt	18,018m	16,986m
Total equity	13,347m	13,671m
Total non current liabilities	-	-
Loans	14,154m	13,703m
Total assets	59,005m	59,463m
Total liabilities	-	-
Cash and cash equivalents	2,746m	3,693m
Common stock	4,056m	4,081m

Cash flow

Year chevron-l-regular chevron-r-regular	2023	2024
Cash at beginning of period	3,425m	2,858m
Cash dividends paid	-2,247m	-2,444m
	4,424m	3,572m
Investments (gains) losses	-1,595m	-1,229m
	2,858m	3,403m
Net income	-	-
	6,768m	6,554m
	-2,344m	-2,982m

The figures shown in the tables are quoted in the currency of the stock selected.

Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.